Sector ratings AbbVie Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:03 15/05/2026 BST			5-day change	1st Jan Change
210.39 ^USD	-0.18%		+4.39%	-7.92%

05-15	Mubadala Investment Co PJSC raises share stake in AbbVie, Match Group, cuts in CVS Health	RE
05-15	Evercore ISI Adjusts Price Target on AbbVie to $235 From $236, Maintains Outperform Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ABBVIE INC.	372B	-	AA	-		-
ELI LILLY AND COMPANY	896B		A
JOHNSON & JOHNSON	546B		BBB
ROCHE HOLDING AG	328B		AA
NOVARTIS AG	283B		AAA
ASTRAZENECA PLC	282B		A
MERCK & CO., INC.	275B		A
NOVO NORDISK A/S	206B		A
AMGEN INC.	176B		A
GILEAD SCIENCES, INC.	161B		AA
PFIZER INC.	144B		A
BRISTOL-MYERS SQUIBB COMPANY	116B		A
VERTEX PHARMACEUTICALS INCORPORATED	111B		AA
SANOFI	103B		AA
GSK PLC	99.05B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	82.33B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.65B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.54B		AA
BAYER AG	43.05B		AA
Average	219.62B		AA
Weighted average by Cap.			AA